177 related articles for article (PubMed ID: 30834688)
1. Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53-dependent apoptosis and anticancer effect.
Kim SG; Seo SH; Shin JH; Yang JP; Lee SH; Shin EH
J Cell Mol Med; 2019 May; 23(5):3234-3245. PubMed ID: 30834688
[TBL] [Abstract][Full Text] [Related]
2. PTEN/AKT signaling pathway related to hTERT downregulation and telomere shortening induced in Toxoplasma GRA16-expressing colorectal cancer cells.
Seo SH; Shin JH; Ham DW; Shin EH
Biomed Pharmacother; 2022 Sep; 153():113366. PubMed ID: 35810694
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.
Dai H; Li M; Yang W; Sun X; Wang P; Wang X; Su J; Wang X; Hu X; Zhao M
Aging (Albany NY); 2020 Jun; 12(12):11717-11731. PubMed ID: 32530437
[TBL] [Abstract][Full Text] [Related]
4. Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression.
Bougdour A; Durandau E; Brenier-Pinchart MP; Ortet P; Barakat M; Kieffer S; Curt-Varesano A; Curt-Bertini RL; Bastien O; Coute Y; Pelloux H; Hakimi MA
Cell Host Microbe; 2013 Apr; 13(4):489-500. PubMed ID: 23601110
[TBL] [Abstract][Full Text] [Related]
5. [PTEN induces apoptosis and up-regulates p53 expression in HepG2 cells].
Yang ZF; Yi JL; Li XR; Xie DX; Liao XF; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):745-8. PubMed ID: 15619344
[TBL] [Abstract][Full Text] [Related]
6. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
8. PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma.
El Sharkawi FZ; Ewais SM; Fahmy RH; Rashed LA
J Drug Target; 2017 Jul; 25(6):513-522. PubMed ID: 28140697
[TBL] [Abstract][Full Text] [Related]
9. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
[TBL] [Abstract][Full Text] [Related]
10.
Seo SH; Kim SG; Shin JH; Ham DW; Shin EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927892
[TBL] [Abstract][Full Text] [Related]
11. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis.
Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B
Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634
[TBL] [Abstract][Full Text] [Related]
13. Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments.
Ohkawa K; Asakura T; Tsukada Y; Matsuura T
Int J Oncol; 2017 Jun; 50(6):2180-2190. PubMed ID: 28498467
[TBL] [Abstract][Full Text] [Related]
14. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
15. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo.
Xiao S; Liu Z; Deng R; Li C; Fu S; Chen G; Zhang X; Ke F; Ke S; Yu X; Wang S; Zhong Z
J Control Release; 2017 Jul; 258():130-145. PubMed ID: 28522194
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis B virus X protein suppresses adriamycin-induced apoptosis of hepatocellular carcinoma cells and expression of p53 and PTEN].
Wang X; Yang L; She JJ; Fan HM; Zhang FC; Chen YM; Xie QF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1775-8. PubMed ID: 20813662
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract][Full Text] [Related]
19. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
